4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-15-002672
Chief Technology Officer acquired 185,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WACHTER ERIC PHD · Chief Technology Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-01-24 | Exercise or conversion : show line 1 in the form | +185,000 | $1.02 | $188,700 | 824,248 | I |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-01-24 | Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) | −185,000 | 800,000 | D |
Loading xslF345X03/doc1.xml…